Global Point-Of-Care Diagnostics Testing (POCT) Market Study 2016-2026, by Segment (Glucose Monitoring, Cardiac Markers, … …), by Market (Clinics, Home, … …), by Company (Abbott Laboratories, Inc, Abaxis, Inc, … …)


The global Point-Of-Care Diagnostics Testing (POCT) market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

Glucose Monitoring
Cardiac Markers
Infectious Diseases Testing
Cholesterol Testing
Coagulation Monitoring
Demand Coverage (Market Size & Forecast, Consumer Distribution):
Assisted living healthcare facilities

Company Coverage (Sales data, Main Products & Services etc.):

Abbott Laboratories, Inc
Abaxis, Inc
Alere, Inc
Bayer AG
Danaher Corporation
Becton, Dickinson And Company
Johnson & Johnson
Nipro Corporation
Roche Diagnostics Limited
Siemens Healthcare
Samsung Medison Co. Ltd

Major Region

North America
South America
Middle East & Africa

Frequently Asked Questions

This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

  • By product type
  • By End User/Applications
  • By Technology
  • By Region

The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.

Please Select a Format

market Reports market Reports